Page 1064 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1064

1050     SECTION X  Special Topics


                 has been shown to have important differentiation-directing   provide such counsel to pregnant women must ensure that their
                 actions in normal tissues. Several vitamin A analogs (isotretinoin,   information is up-to-date and evidence-based and that the woman
                 etretinate) are powerful teratogens, suggesting that they alter the   understands that the baseline teratogenic risk in pregnancy (ie,
                 normal processes of differentiation. Finally, deficiency of a critical   the risk of a neonatal abnormality in the absence of any known
                 substance appears to play a role in some types of abnormalities.   teratogenic exposure) is about 3%. It is also critical to address the
                 For example, folic acid supplementation during pregnancy appears   maternal-fetal risks of the untreated condition if a medication is
                 to reduce the incidence of neural tube defects (see Box, page 599).  avoided. Recent studies show serious morbidity in women who
                   Continued exposure to a teratogen may produce cumulative   discontinued selective serotonin reuptake inhibitor therapy for
                 effects or may affect several organs going through varying stages of   depression in pregnancy.
                 development. Chronic consumption of high doses of ethanol dur-
                 ing pregnancy, particularly during the first and second trimesters,
                 may result in the fetal alcohol spectrum disorder (see Chapter 23).   DRUG THERAPY IN INFANTS & CHILDREN
                 In this syndrome, the central nervous system, growth, and facial
                 development may be affected.                        Physiologic processes that influence pharmacokinetic variables in
                                                                     the infant change significantly in the first year of life, particularly
                 2. Defining  a teratogen—To  be  considered  teratogenic, a   during the first few months. Therefore, special attention must be
                 candidate substance or process should (1) result in a character-  paid to pharmacokinetics in this age group. Pharmacodynamic
                 istic set of malformations, indicating selectivity for certain target   differences between pediatric and other patients have not been
                 organs; (2) exert its effects at a particular stage of fetal develop-  explored in great detail but are probably important for those spe-
                 ment, eg, during the limited time period of organogenesis of   cific target tissues that mature at birth or immediately thereafter
                 the target organs (Figure 59–1); and (3) show a dose-dependent   (eg, the ductus arteriosus).
                 incidence. Some drugs with known teratogenic or other adverse
                 effects in pregnancy are listed in Table 59–1. Teratogenic effects   Drug Absorption
                 are not limited only to major malformations, but also include   Drug absorption in infants and children follows the same gen-
                 intrauterine growth restriction (eg, cigarette smoking), miscarriage   eral principles as in adults. Unique factors that influence drug
                 (eg, alcohol), stillbirth (eg, cigarette smoke), and neurocognitive   absorption include blood flow at the site of administration, as
                 delay (eg, alcohol, valproic acid).                 determined by the physiologic status of the infant or child; and,
                   In addition to teratogenic drugs, teratogenicity can be induced   for orally administered drugs, gastrointestinal function, which
                 by a large group of infectious pathogens, including viruses such   changes rapidly during the first few days after birth. Age after
                 as rubella, cytomegalovirus, herpes, and recently, Zika virus.   birth also influences the regulation of drug absorption.
                 Similarly, numerous chemicals, such as heavy metals (eg, mercury,
                 lead) and environmental factors (eg, radiation, hyperthermia) can
                 damage the fetus. It is important to consider these nondrug factors   A. Blood Flow at the Site of Administration
                 in the differential diagnosis of drug-induced adverse fetal effects.  Absorption after intramuscular or subcutaneous injection depends
                   The widely cited US Food and Drug Administration (FDA)   mainly, in neonates as in adults, on the rate of blood flow to the
                 system for teratogenic potential (Table 59–2) has been an attempt   muscle or subcutaneous area injected. Physiologic conditions that
                 to quantify teratogenic risk from A (safe) to X (definite human   might reduce blood flow to these areas are cardiovascular shock,
                 teratogenic risk).  This system has been criticized as inaccurate   vasoconstriction due to sympathomimetic agents, and heart failure.
                 and impractical. For example, several drugs have been labeled “X”   However, sick preterm infants requiring intramuscular injections
                 despite extensive opposite human safety data (eg, oral contracep-  may have very little muscle mass.  This is further complicated
                 tives). Diazepam and other benzodiazepines are labeled as “D”   by diminished peripheral perfusion to these areas. In such cases,
                 despite lack of positive evidence of human fetal risk. The FDA   absorption becomes irregular and difficult to predict, because the
                 has recently changed its system from the A, B, C grading system   drug may remain in the muscle and be absorbed more slowly than
                 to narrative statements that summarize evidence-based knowledge   expected. If perfusion suddenly improves, there can be a sudden
                 about each drug in terms of fetal risk and safety.  and unpredictable increase in the amount of drug entering the cir-
                                                                     culation, resulting in high and potentially toxic concentrations of
                 3. Counseling women about teratogenic risk—Since the   drug. Examples of drugs especially hazardous in such situations are
                 thalidomide disaster, medicine has been practiced as if every drug   cardiac glycosides, aminoglycoside antibiotics, and anticonvulsants.
                 were a potential human teratogen when, in fact, fewer than 30
                 such drugs have been identified, with hundreds of agents proved   B. Gastrointestinal Function
                 safe  for  the unborn.  Owing  to  high  levels of  anxiety  among   Significant biochemical and physiologic changes occur in the
                 pregnant women—and because half of the pregnancies in North   neonatal gastrointestinal tract shortly after birth. In full-term
                 America are unplanned—every year many thousands of women   infants, gastric acid secretion begins soon after birth and increases
                 need counseling about fetal exposure to drugs, chemicals, and   gradually over several hours. In preterm infants, the secretion of
                 radiation. The ability of appropriate counseling to prevent unnec-  gastric acid occurs more slowly, with the highest concentrations
                 essary abortions has been documented. Clinicians who wish to   appearing on the fourth day of life.
   1059   1060   1061   1062   1063   1064   1065   1066   1067   1068   1069